Description
The monitoring of adverse events following immunization (AEFI) involving vaccines and biologicals administered in Alberta is an important evaluation component of the provincial immunization program. This document has been developed specifically for COVID-19 vaccine AEFI active surveillance. Active AEFI surveillance for COVID-19 vaccine in Alberta involves a collaboration between Alberta Health, Alberta Health Services Provincial AEFI Team, and the Canadian National Vaccine Safety Network (CANVAS).
Updated
February 25, 2022
Tags
Resources
-
COVID-19 vaccine : active surveillance and reporting of adverse events following immunization (AEFI) [February 25, 2022]
Downloads: 1606
-
[SUPERSEDED] - COVID-19 vaccine : active surveillance and reporting of adverse events following immunization (AEFI) [December 15, 2021]
Downloads: 768
-
[SUPERSEDED] - COVID-19 vaccine : active surveillance and reporting of adverse events following immunization (AEFI) [July 15, 2021]
Downloads: 2743
-
[SUPERSEDED] - COVID-19 vaccine : active surveillance and reporting of adverse events following immunization (AEFI) [June 15, 2021]
Downloads: 1075
-
[SUPERSEDED] - COVID-19 vaccine : active surveillance and reporting of adverse events following immunization (AEFI) [April 27, 2021]
Downloads: 1501
-
[SUPERSEDED] - COVID-19 vaccine : active surveillance and reporting of adverse events following immunization (AEFI) [February 4, 2021]
Downloads: 1783
-
[SUPERSEDED] - COVID-19 vaccine : active surveillance and reporting of adverse events following immunization (AEFI) [December 2020]
Downloads: 1270
Title and publication information
Type
Extent
21 pages
Frequency
Irregular
Publisher / Creator Information
Subject Information
Topic
Resource Dates
Date Created
2020-12-28
Date Added
2020-12-28T20:23:10.331576
Date Modified
2022-02-25
Date Issued
2020-12-28